1. Home
  2. TRMB vs RDY Comparison

TRMB vs RDY Comparison

Compare TRMB & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRMB
  • RDY
  • Stock Information
  • Founded
  • TRMB 1978
  • RDY 1984
  • Country
  • TRMB United States
  • RDY India
  • Employees
  • TRMB N/A
  • RDY N/A
  • Industry
  • TRMB Industrial Machinery/Components
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRMB Industrials
  • RDY Health Care
  • Exchange
  • TRMB Nasdaq
  • RDY Nasdaq
  • Market Cap
  • TRMB 15.1B
  • RDY 13.1B
  • IPO Year
  • TRMB 1990
  • RDY N/A
  • Fundamental
  • Price
  • TRMB $70.62
  • RDY $14.17
  • Analyst Decision
  • TRMB Buy
  • RDY Buy
  • Analyst Count
  • TRMB 6
  • RDY 1
  • Target Price
  • TRMB $74.83
  • RDY $17.00
  • AVG Volume (30 Days)
  • TRMB 1.2M
  • RDY 697.0K
  • Earning Date
  • TRMB 11-06-2024
  • RDY 11-05-2024
  • Dividend Yield
  • TRMB N/A
  • RDY 6.76%
  • EPS Growth
  • TRMB 342.93
  • RDY 4.63
  • EPS
  • TRMB 5.97
  • RDY 0.76
  • Revenue
  • TRMB $3,632,300,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • TRMB N/A
  • RDY $13.39
  • Revenue Next Year
  • TRMB N/A
  • RDY $8.35
  • P/E Ratio
  • TRMB $11.83
  • RDY $19.00
  • Revenue Growth
  • TRMB N/A
  • RDY 12.37
  • 52 Week Low
  • TRMB $42.83
  • RDY $12.90
  • 52 Week High
  • TRMB $74.22
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • TRMB 67.80
  • RDY 30.39
  • Support Level
  • TRMB $71.17
  • RDY $14.99
  • Resistance Level
  • TRMB $74.22
  • RDY $15.19
  • Average True Range (ATR)
  • TRMB 1.83
  • RDY 0.28
  • MACD
  • TRMB 0.61
  • RDY -0.07
  • Stochastic Oscillator
  • TRMB 74.08
  • RDY 11.43

About TRMB Trimble Inc.

Trimble Inc provides a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has four reportable segments: Buildings and Infrastructure, Geospatial, Resources and Utilities, and Transportation. The company generates the majority of its revenue from the Buildings and Infrastructure segment, which primarily serves customers working in architecture, engineering, construction, design, asset management, operations, and maintenance.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: